UKE Homepage
Our research projects address different aspects of the disease cascade in arrhythmogenic cardiomyopathy (ACM):
1. Early disease mechanisms:
We integrate cardiac function data with spatio-temporal gene expression patterns to identify early molecular drivers of arrhythmias and cardiac fibrosis. Our goal is to pinpoint changes that occur in the very initial phases of ACM.
2. Cell-type-specific mechanisms:
We investigate the role of distinct cardiac cell subtypes in disease progression and how they modulate the ACM phenotype. Special focus is placed on intercellular communication and remodeling processes.
3. Pro-adhesive therapeutic strategies:
Based on our recent findings on defective cell-cell adhesion in ACM (Schinner et al., Circulation, 2022), we evaluate the therapeutic potential of compounds that restore adhesion and potentially counteract disease progression.
4. Immune-mediated components:
We assess the contribution of both circulating and tissue-resident immune factors and explore how targeted modulation could provide new therapeutic avenues.
Arturo Aguado Gonzales
PhD student
Adrita Chanda,
PhD student
Patricia Manske,
MD student